aluates Reports

$ 0.0

Automative

Global CAR-T Cellular Immunotherapy Drug Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-37R14132

Global CAR T Cellular Immunotherapy Drug Market Research Report 2023

BUY CHAPTERS

Global CAR-T Cellular Immunotherapy Drug Market Research Report 2025

Code: QYRE-Auto-37R14132

Report

September 2025

Pages:64

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novartis

Kite Pharma

Bristol–Myers Squibb

Fosun Pharma

CAR-T Cellular Immunotherapy Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

CAR-T Cellular Immunotherapy Drug Market

The global market for CAR-T Cellular Immunotherapy Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for CAR-T Cellular Immunotherapy Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR-T Cellular Immunotherapy Drug.

The CAR-T Cellular Immunotherapy Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CAR-T Cellular Immunotherapy Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the CAR-T Cellular Immunotherapy Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of CAR-T Cellular Immunotherapy Drug Market Report

Report Metric	Details
Report Name	CAR-T Cellular Immunotherapy Drug Market
CAGR	5%
Segment by Type	CD19-Targeted BCMA-Targeted
Segment by Application	Multiple Myeloma Non-Hodgkin lymphoma Leukemia
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novartis AG, Kite Pharma, Bristol Myers Squibb, Fosun Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CAR-T Cellular Immunotherapy Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the CAR-T Cellular Immunotherapy Drug Market report?

Ans: The main players in the CAR-T Cellular Immunotherapy Drug Market are Novartis AG, Kite Pharma, Bristol Myers Squibb, Fosun Pharma

What are the Application segmentation covered in the CAR-T Cellular Immunotherapy Drug Market report?

Ans: The Applications covered in the CAR-T Cellular Immunotherapy Drug Market report are Multiple Myeloma, Non-Hodgkin lymphoma, Leukemia

What are the Type segmentation covered in the CAR-T Cellular Immunotherapy Drug Market report?

Ans: The Types covered in the CAR-T Cellular Immunotherapy Drug Market report are CD19-Targeted, BCMA-Targeted

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global CAR-T Cellular Immunotherapy Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 CD19-Targeted

1.2.3 BCMA-Targeted

1.3 Market by Application

1.3.1 Global CAR-T Cellular Immunotherapy Drug Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Multiple Myeloma

1.3.3 Non-Hodgkin lymphoma

1.3.4 Leukemia

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global CAR-T Cellular Immunotherapy Drug Market Perspective (2020-2031)

2.2 Global CAR-T Cellular Immunotherapy Drug Growth Trends by Region

2.2.1 Global CAR-T Cellular Immunotherapy Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 CAR-T Cellular Immunotherapy Drug Historic Market Size by Region (2020-2025)

2.2.3 CAR-T Cellular Immunotherapy Drug Forecasted Market Size by Region (2026-2031)

2.3 CAR-T Cellular Immunotherapy Drug Market Dynamics

2.3.1 CAR-T Cellular Immunotherapy Drug Industry Trends

2.3.2 CAR-T Cellular Immunotherapy Drug Market Drivers

2.3.3 CAR-T Cellular Immunotherapy Drug Market Challenges

2.3.4 CAR-T Cellular Immunotherapy Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top CAR-T Cellular Immunotherapy Drug Players by Revenue

3.1.1 Global Top CAR-T Cellular Immunotherapy Drug Players by Revenue (2020-2025)

3.1.2 Global CAR-T Cellular Immunotherapy Drug Revenue Market Share by Players (2020-2025)

3.2 Global CAR-T Cellular Immunotherapy Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by CAR-T Cellular Immunotherapy Drug Revenue

3.4 Global CAR-T Cellular Immunotherapy Drug Market Concentration Ratio

3.4.1 Global CAR-T Cellular Immunotherapy Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by CAR-T Cellular Immunotherapy Drug Revenue in 2024

3.5 Global Key Players of CAR-T Cellular Immunotherapy Drug Head office and Area Served

3.6 Global Key Players of CAR-T Cellular Immunotherapy Drug, Product and Application

3.7 Global Key Players of CAR-T Cellular Immunotherapy Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 CAR-T Cellular Immunotherapy Drug Breakdown Data by Type

4.1 Global CAR-T Cellular Immunotherapy Drug Historic Market Size by Type (2020-2025)

4.2 Global CAR-T Cellular Immunotherapy Drug Forecasted Market Size by Type (2026-2031)

5 CAR-T Cellular Immunotherapy Drug Breakdown Data by Application

5.1 Global CAR-T Cellular Immunotherapy Drug Historic Market Size by Application (2020-2025)

5.2 Global CAR-T Cellular Immunotherapy Drug Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America CAR-T Cellular Immunotherapy Drug Market Size (2020-2031)

6.2 North America CAR-T Cellular Immunotherapy Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America CAR-T Cellular Immunotherapy Drug Market Size by Country (2020-2025)

6.4 North America CAR-T Cellular Immunotherapy Drug Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe CAR-T Cellular Immunotherapy Drug Market Size (2020-2031)

7.2 Europe CAR-T Cellular Immunotherapy Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe CAR-T Cellular Immunotherapy Drug Market Size by Country (2020-2025)

7.4 Europe CAR-T Cellular Immunotherapy Drug Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific CAR-T Cellular Immunotherapy Drug Market Size (2020-2031)

8.2 Asia-Pacific CAR-T Cellular Immunotherapy Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific CAR-T Cellular Immunotherapy Drug Market Size by Region (2020-2025)

8.4 Asia-Pacific CAR-T Cellular Immunotherapy Drug Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America CAR-T Cellular Immunotherapy Drug Market Size (2020-2031)

9.2 Latin America CAR-T Cellular Immunotherapy Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America CAR-T Cellular Immunotherapy Drug Market Size by Country (2020-2025)

9.4 Latin America CAR-T Cellular Immunotherapy Drug Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa CAR-T Cellular Immunotherapy Drug Market Size (2020-2031)

10.2 Middle East & Africa CAR-T Cellular Immunotherapy Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa CAR-T Cellular Immunotherapy Drug Market Size by Country (2020-2025)

10.4 Middle East & Africa CAR-T Cellular Immunotherapy Drug Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Novartis AG

11.1.1 Novartis AG Company Details

11.1.2 Novartis AG Business Overview

11.1.3 Novartis AG CAR-T Cellular Immunotherapy Drug Introduction

11.1.4 Novartis AG Revenue in CAR-T Cellular Immunotherapy Drug Business (2020-2025)

11.1.5 Novartis AG Recent Development

11.2 Kite Pharma

11.2.1 Kite Pharma Company Details

11.2.2 Kite Pharma Business Overview

11.2.3 Kite Pharma CAR-T Cellular Immunotherapy Drug Introduction

11.2.4 Kite Pharma Revenue in CAR-T Cellular Immunotherapy Drug Business (2020-2025)

11.2.5 Kite Pharma Recent Development

11.3 Bristol Myers Squibb

11.3.1 Bristol Myers Squibb Company Details

11.3.2 Bristol Myers Squibb Business Overview

11.3.3 Bristol Myers Squibb CAR-T Cellular Immunotherapy Drug Introduction

11.3.4 Bristol Myers Squibb Revenue in CAR-T Cellular Immunotherapy Drug Business (2020-2025)

11.3.5 Bristol Myers Squibb Recent Development

11.4 Fosun Pharma

11.4.1 Fosun Pharma Company Details

11.4.2 Fosun Pharma Business Overview

11.4.3 Fosun Pharma CAR-T Cellular Immunotherapy Drug Introduction

11.4.4 Fosun Pharma Revenue in CAR-T Cellular Immunotherapy Drug Business (2020-2025)

11.4.5 Fosun Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Novartis

Kite Pharma

Bristol–Myers Squibb

Fosun Pharma

List of Tables

Table 1. Global CAR-T Cellular Immunotherapy Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of CD19-Targeted

Table 3. Key Players of BCMA-Targeted

Table 4. Global CAR-T Cellular Immunotherapy Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global CAR-T Cellular Immunotherapy Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global CAR-T Cellular Immunotherapy Drug Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global CAR-T Cellular Immunotherapy Drug Market Share by Region (2020-2025)

Table 8. Global CAR-T Cellular Immunotherapy Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global CAR-T Cellular Immunotherapy Drug Market Share by Region (2026-2031)

Table 10. CAR-T Cellular Immunotherapy Drug Market Trends

Table 11. CAR-T Cellular Immunotherapy Drug Market Drivers

Table 12. CAR-T Cellular Immunotherapy Drug Market Challenges

Table 13. CAR-T Cellular Immunotherapy Drug Market Restraints

Table 14. Global CAR-T Cellular Immunotherapy Drug Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global CAR-T Cellular Immunotherapy Drug Market Share by Players (2020-2025)

Table 16. Global Top CAR-T Cellular Immunotherapy Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Cellular Immunotherapy Drug as of 2024)

Table 17. Ranking of Global Top CAR-T Cellular Immunotherapy Drug Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by CAR-T Cellular Immunotherapy Drug Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of CAR-T Cellular Immunotherapy Drug, Headquarters and Area Served

Table 20. Global Key Players of CAR-T Cellular Immunotherapy Drug, Product and Application

Table 21. Global Key Players of CAR-T Cellular Immunotherapy Drug, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global CAR-T Cellular Immunotherapy Drug Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global CAR-T Cellular Immunotherapy Drug Revenue Market Share by Type (2020-2025)

Table 25. Global CAR-T Cellular Immunotherapy Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global CAR-T Cellular Immunotherapy Drug Revenue Market Share by Type (2026-2031)

Table 27. Global CAR-T Cellular Immunotherapy Drug Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global CAR-T Cellular Immunotherapy Drug Revenue Market Share by Application (2020-2025)

Table 29. Global CAR-T Cellular Immunotherapy Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global CAR-T Cellular Immunotherapy Drug Revenue Market Share by Application (2026-2031)

Table 31. North America CAR-T Cellular Immunotherapy Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America CAR-T Cellular Immunotherapy Drug Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America CAR-T Cellular Immunotherapy Drug Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe CAR-T Cellular Immunotherapy Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe CAR-T Cellular Immunotherapy Drug Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe CAR-T Cellular Immunotherapy Drug Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific CAR-T Cellular Immunotherapy Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific CAR-T Cellular Immunotherapy Drug Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific CAR-T Cellular Immunotherapy Drug Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America CAR-T Cellular Immunotherapy Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America CAR-T Cellular Immunotherapy Drug Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America CAR-T Cellular Immunotherapy Drug Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa CAR-T Cellular Immunotherapy Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa CAR-T Cellular Immunotherapy Drug Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa CAR-T Cellular Immunotherapy Drug Market Size by Country (2026-2031) & (US$ Million)

Table 46. Novartis AG Company Details

Table 47. Novartis AG Business Overview

Table 48. Novartis AG CAR-T Cellular Immunotherapy Drug Product

Table 49. Novartis AG Revenue in CAR-T Cellular Immunotherapy Drug Business (2020-2025) & (US$ Million)

Table 50. Novartis AG Recent Development

Table 51. Kite Pharma Company Details

Table 52. Kite Pharma Business Overview

Table 53. Kite Pharma CAR-T Cellular Immunotherapy Drug Product

Table 54. Kite Pharma Revenue in CAR-T Cellular Immunotherapy Drug Business (2020-2025) & (US$ Million)

Table 55. Kite Pharma Recent Development

Table 56. Bristol Myers Squibb Company Details

Table 57. Bristol Myers Squibb Business Overview

Table 58. Bristol Myers Squibb CAR-T Cellular Immunotherapy Drug Product

Table 59. Bristol Myers Squibb Revenue in CAR-T Cellular Immunotherapy Drug Business (2020-2025) & (US$ Million)

Table 60. Bristol Myers Squibb Recent Development

Table 61. Fosun Pharma Company Details

Table 62. Fosun Pharma Business Overview

Table 63. Fosun Pharma CAR-T Cellular Immunotherapy Drug Product

Table 64. Fosun Pharma Revenue in CAR-T Cellular Immunotherapy Drug Business (2020-2025) & (US$ Million)

Table 65. Fosun Pharma Recent Development

Table 66. Research Programs/Design for This Report

Table 67. Key Data Information from Secondary Sources

Table 68. Key Data Information from Primary Sources

Table 69. Authors List of This Report

List of Figures

Figure 1. CAR-T Cellular Immunotherapy Drug Picture

Figure 2. Global CAR-T Cellular Immunotherapy Drug Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global CAR-T Cellular Immunotherapy Drug Market Share by Type: 2024 VS 2031

Figure 4. CD19-Targeted Features

Figure 5. BCMA-Targeted Features

Figure 6. Global CAR-T Cellular Immunotherapy Drug Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global CAR-T Cellular Immunotherapy Drug Market Share by Application: 2024 VS 2031

Figure 8. Multiple Myeloma Case Studies

Figure 9. Non-Hodgkin lymphoma Case Studies

Figure 10. Leukemia Case Studies

Figure 11. CAR-T Cellular Immunotherapy Drug Report Years Considered

Figure 12. Global CAR-T Cellular Immunotherapy Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global CAR-T Cellular Immunotherapy Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global CAR-T Cellular Immunotherapy Drug Market Share by Region: 2024 VS 2031

Figure 15. Global CAR-T Cellular Immunotherapy Drug Market Share by Players in 2024

Figure 16. Global Top CAR-T Cellular Immunotherapy Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Cellular Immunotherapy Drug as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by CAR-T Cellular Immunotherapy Drug Revenue in 2024

Figure 18. North America CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America CAR-T Cellular Immunotherapy Drug Market Share by Country (2020-2031)

Figure 20. United States CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe CAR-T Cellular Immunotherapy Drug Market Share by Country (2020-2031)

Figure 24. Germany CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific CAR-T Cellular Immunotherapy Drug Market Share by Region (2020-2031)

Figure 32. China CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America CAR-T Cellular Immunotherapy Drug Market Share by Country (2020-2031)

Figure 40. Mexico CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa CAR-T Cellular Immunotherapy Drug Market Share by Country (2020-2031)

Figure 44. Turkey CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Novartis AG Revenue Growth Rate in CAR-T Cellular Immunotherapy Drug Business (2020-2025)

Figure 48. Kite Pharma Revenue Growth Rate in CAR-T Cellular Immunotherapy Drug Business (2020-2025)

Figure 49. Bristol Myers Squibb Revenue Growth Rate in CAR-T Cellular Immunotherapy Drug Business (2020-2025)

Figure 50. Fosun Pharma Revenue Growth Rate in CAR-T Cellular Immunotherapy Drug Business (2020-2025)

Figure 51. Bottom-up and Top-down Approaches for This Report

Figure 52. Data Triangulation

Figure 53. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

CAR T Cell Therapy Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Chimeric Antigen Receptor CAR T Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

CAR T Therapy in Haematological Malignancy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancers Immunotherapy Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chimeric Antigen Receptor Cell Therapy Market Research Report 2024

Tumor Immunotherapy Market

T Cell Lymphoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cell Therapy Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

TCR Based Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cellular and Gene Therapy Product Market Research Report 2025

Next Generation Immunology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Immune Drugs Market Insights Forecast to 2030

Global Cell Therapy CMO Market Research Report 2025

Cutaneous Cell Lymphoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancer Stem Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hairy Cell Leukemia Therapeutics Market Research Report 2024

Global Autoimmune Diseases Treatment Market Research Report 2024

Non Small Cell Lung Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Immune System Allergy Treatment Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions